tuspetinib (HM43239) - Aptose Biosci
Venclexta (venetoclax) - Roche, AbbVie, Walter and Eliza Hall Institute
brequinar (DUP 785) - BMS, Clear Creek Bio
Xospata (gilteritinib) - Astellas
Vanflyta (quizartinib) - Daiichi Sankyo
azacitidine - Generic mfg.
luxeptinib (CG-806) - Aptose Biosci
zelavespib intravenous (PU-H71 IV) - Samus Therap
https://library.ehaweb.org/eha/2023/eha2023-congress/386894/himangshu.sonowal.in.vitro.acquired.resistance.to.the.oral.myeloid.kinase.html?f=menu%3D16%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2489%2Aot_id%3D27912%2Atrend%3D4016%2Amarker%3D4179
 
Himangshu Sonowal; Rafael Bejar; William Rice; Stephen Howell
 
May 12, 2023
 
Prev Next